
Trump Admin Fast-Tracks Psychedelic Therapies for Serious Mental Illness
Trump signs an executive order to accelerate psychedelic therapies for serious mental illness, directing FDA to use national priority vouchers for breakthrough psychedelic drugs, create pathways to access investigational psychedelics under the Right to Try Act, and invest $50 million via ARPA-H to boost research; the plan calls for VA and private‑sector collaboration to expand trials and aims to help veterans and reduce suicide, building on prior Right to Try and drug research reforms.







